Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation

Jahnke S, Schmid H, Secker KA, Duerr-Stoerzer S, Keppeler H, Schumm M, Handgretinger R, Bethge W, Kanz L, Schneidawind C, Schneidawind D, Baur R (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Blood American Society of Hematology

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

Event location: San Diego, CA US

DOI: 10.1182/blood-2018-99-111745

Authors with CRIS profile

Rebecca Baur Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Universitätsklinikum Tübingen DE Germany (DE)

How to cite

APA:

Jahnke, S., Schmid, H., Secker, K.-A., Duerr-Stoerzer, S., Keppeler, H., Schumm, M.,... Baur, R. (2018). Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Jahnke, Simona, et al. "Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.

BibTeX: Download